Patients diagnosed with and pharmacologically treated for essential Arterial hypertension arterial hypertension community pharmacy care program health results pharmaceutical intervention blood pressure control
Conditions
Interventions
A randomized controlled trial by conglomerates of 6 months was carried out,
with assignment of community pharmacies to intervention or control group. The patients in the intervention group received the community pharmaceutical intervention based on a protocol that addresses t
which included Health Education,
Pharmacotherapy Follow-
up and 24-
hour Ambulatory Blood Pressure Measurement. In contrast,
the control patients received usual care in the community pharmacy to a pharmacologically treated hypertensive patient. The main variables were BP control,
use of health resources and quality of life. These variables were determined at the beginning and at the end of the study.,The pharmacists of the CG received instructions by phone and email about the
in addition to perform usual pharmaceutical care in the community pharmacy to hypertensive patients treated pharmacologically. These patients made two visits to the pharmacy during their monitoring
at the beginning and at the end of the stud and received the usual assistance in the community pharmacy in the pharmacologically treated hypertensive patient
Sham Comparator Other,No Intervention Other
hour Ambulatory Blood Pressure Measurement, the control patients received usual care in the community pharmacy to a pharmacologically treated h
Sponsors
The Phcare Foundation Institution received PFIZER payments for 2 AMBP devices, and courses to pharma
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Patients diagnosed with and pharmacologically treated for essential AHT, who were literate, in full possession of their mental faculties and willing to be monitored for 6 months, were included
Exclusion criteria
Exclusion criteria: Patients with arrythmia or secondary AHT or who were pregnant were excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| arterial hypertension 6 months community pharmaceutical care intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| N/A N/A N/A | — |
Countries
spain
Contacts
Public Contactraul luque del moral
Group Research in Pharmacy Care University of Granada (Spain)
Outcome results
None listed